The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma

Paolo Gobbi, Vittorio Rosti, Francesco Valentino, Elisa Bonetti, Francesco Merli, Caterina Stelitano, Alessandra Dondi, Giovanni Quarta, Simona Falorio, Massimo Federico

Research output: Contribution to journalArticle

Abstract

Background: The early stem cell reservoir can be impaired by a few cycles of chemotherapy, and this impairment might persist after normalization of peripheral cytopenias. We directly evaluated the damage caused to marrow progenitor cells by 3 currently used chemotherapy regimens for advanced Hodgkin lymphoma. Patients and Methods: Bone marrow samples from 37 patients randomly treated according to either the ABVD (doxorubicin/bleomycin/vinblastine/ dacarbazine), COPPEBVCAD (cyclophosphamide/vincristine/procarbazine/prednisone/ epirubicin/bleomycin/vinblastine/lomustine/melphalan/ vindesine), or BEACOPP (bleomycin/etoposide/doxorubicin/cyclophosphamide/vincristine/procarbazine/ prednisone) schedule were taken a few days before the start of chemotherapy and 30 days and 6 months after its completion. Samples were cryopreserved, thawed in a single session, and cultured for 5 weeks to detect long-term culture-initiating cells (LTC-IC). Results: On the basis of the numbers of LTC-IC detected and of their relative variations, the ABVD regimen was associated with the least early reduction and the best late recovery of LTC-IC. COPPEBVCAD produced the greatest early damage, but recovery was nearly complete by 6 months. BEACOPP caused intermediate early toxicity that persisted at 6 months. Conclusion: The different late toxicity exerted on marrow progenitors by these chemotherapy regimens should be carefully weighed in relation to both the expected early response rate and subsequent possibility of rescue in the case of first treatment failure.

Original languageEnglish
Pages (from-to)425-429
Number of pages5
JournalClinical Lymphoma and Myeloma
Volume9
Issue number6
DOIs
Publication statusPublished - Dec 1 2009

Keywords

  • ABVD
  • BEACOPP
  • COPPEBVCAD
  • Hodgkin's lymphoma
  • Long-term culture-initiating cell
  • Myelosuppression

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Hematology

Fingerprint Dive into the research topics of 'The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma'. Together they form a unique fingerprint.

  • Cite this